Clinical Trials Browser

Phase 3 × Dexamethasone × Myeloid × Clear all

NCT02912702 2016-09-23

L-DEP as an Initial Treatment for EBV-HLH

Phase 3 Unknown

Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

NCT00002517 2010-06-22

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Phase 3 Completed

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic